Medium-Term Targets for Distribution Value, Consolidated Revenue, EBITDA and EPS
First written in FY2020. 4 of 10 entries say "Restated". Latest entry: 2026-10-14.
The whole theme swung hardest in 2021: 17 of 77 companies on the "Worse" side.
- 2026-10-14Advancedwww.nikkei.com
「Notice Regarding Upward Revisions to Earnings Forecasts and Dividend Forecasts」
A new disclosure reportedly announced an upward revision to the earnings forecast. - 2026-05-29RestatedInvestor presentation
「27/2期の業績予想は、売上高1,180億円（前年比+8.7％）、営業利益24.0億円（-2.2％）、当期純利益12.0億円（-34.0％）となっています(営業利益の増減要因の詳細については次のページで説明いたします)。」
2027年2月期について、売上高、営業利益、当期純利益及びEBITDAの数値計画を改めて示している。 - FY2026ReframedAnnual report
「Net sales ¥108.5 billion ¥118.0 billion ¥115.0 billion ¥125.0 billion / Operating profit ¥2.45 billion ¥2.40 billion ¥3.22 billion ¥4.00 billion / EBITDA ¥3.66 billion ¥4.10 billion ¥4.50 billion ¥5.20 billion / Net income attributable to owners of the parent ¥1.81 billion ¥1.20 billion ¥2.15 billion ¥2.50 billion」
Based on the new medium-term management plan, the company newly presented actual results for the fiscal year ending February 2026 and targets for net sales, operating profit, EBITDA and net income for the fiscal years ending February 2027, February 2028 and February 2030. - FY2026-H1RestatedAnnual report
「These factors were already incorporated into the initial plan, and progress toward achieving the full-year plan is in line with expectations.」
The factors contributing to the increase in interim net income attributable to owners of the parent had already been incorporated into the initial plan, and the company explained that progress toward the full-year plan was in line with expectations. - FY2024SoftenedAnnual report
「The performance targets in the medium-term management plan are currently under review in light of recent changes in the external and internal environment.」
The company stated that it was reviewing the future performance targets in the previous medium-term management plan, and this filing no longer maintains the FY2027 targets for net sales and profit, shifting to disclosure centered on the plan for the fiscal year ending February 2025. - FY2022RaisedAnnual report
「Net sales ¥104.7 billion ¥100.0 billion ¥120.0 billion ¥150.0 billion / Operating profit ¥2.81 billion ¥2.00 billion ¥4.0 billion ¥8.5 billion / EBITDA ¥3.92 billion ¥3.59 billion ¥5.5 billion ¥10.0 billion / Net income ¥1.57 billion ¥0.85 billion ¥2.8 billion ¥6.0 billion / ROE 10.9% 5.2% 15.0% 23.0%」
The company has set new medium-term management targets for the fiscal year ending February 2027 of net sales of ¥150.0 billion, operating profit of ¥8.5 billion, EBITDA of ¥10.0 billion, net income of ¥6.0 billion and ROE of 23.0%. - FY2021RaisedAnnual report
「Fiscal year ended February 2021: Actual; total distribution value ¥155.0 billion; consolidated net sales ¥83.5 billion; consolidated EBITDA ¥3.4 billion; EPS ¥104.52 / Fiscal year ending February 2022: Plan; total distribution value ¥185.0 billion; consolidated net sales ¥100.0 billion; consolidated EBITDA ¥4.0 billion; EPS ¥100.90」
The plan for the fiscal year ending February 2022 was set at a total distribution value of ¥185.0 billion, consolidated net sales of ¥100.0 billion, EBITDA of ¥4.0 billion and EPS of ¥100.90. Compared with the previous plan for the fiscal year ending February 2021, the planned total distribution value, net sales and EBITDA were increased. - FY2020First statedAnnual report
「Fiscal year ending February 2020: actual—total distribution value ¥120.0 billion, consolidated sales ¥65.8 billion, consolidated EBITDA ¥2.6 billion and EPS ¥65. Fiscal year ending February 2021: plan—total distribution value ¥140.0 billion, consolidated sales ¥77.0 billion, consolidated EBITDA ¥3.0 billion and EPS ¥77. Fiscal year ending February 2023: plan—total distribution value ¥165.0 billion, consolidated sales ¥90.0 billion, consolidated EBITDA ¥6.0 billion and EPS ¥135.」
Sets numerical targets for total distribution value, sales, EBITDA and EPS for the fiscal years ending February 2021 and February 2023.